Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001055726-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-28 | 2025-02-26 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | — | +5,010 | 13.2K | +61% | — |
| DM | 2025-02-28 | 2025-02-27 | INO | Sumner Michael John | Chief Medical Off | A - Grant | $0.00 | +77.5K | 42.9K | New | $0 |
| D | 2025-02-28 | 2025-02-26 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | $0.00 | -5,010 | 10.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | M | A | 5,010 | — | 13,229 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Derivative | Restricted Stock Unit | 2025-02-27 | A | A | 34,650 | $0.00 | 34,650 | D | — · — to — | 34,650 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 is as follows: 11,550 shares will vest on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 5,010 | $0.00 | 10,019 | D | — · — to — | 5,010 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Derivative | Common Stock Option | 2025-02-27 | A | A | 42,900 | $0.00 | 42,900 | D | $1.94 · 2025-02-27 to 2035-02-27 | 42,900 Common Stock | (F2) The vesting schedule for the 42,900 options is as follows: 21,450 shares vested on February 27, 2025 and 21,450 shares will vest on February 26, 2026. |